HEALTH● LOW1h ago · Oct 9, 2026, 3:54 PM
Johnson & Johnson says long-term data boosts Icotyde for plaque psoriasis
Seeking Alpha Tech · global
Johnson & Johnson has reported that long-term data supports the effectiveness of Icotyde for treating plaque psoriasis. This indicates a positive development for the drug in addressing a medical condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH36m agoDid Russia play by the rules in reporting lab worker's death?NPR NewsHEALTH41m agoDoes each new covid-19 variant pose a significant threat?New ScientistHEALTH47m agoMaps and charts show record number of measles cases in U.S. this yearCBS NewsHEALTH59m agoSri Narayani Hospital completes 125 kidney transplants in Vellore, honours doctorsThe Hindu